Reduced levels of IGF-1 lead to development of GH resistance [56], decreased expression of GHR [112] due to hepatocellular damage by tumor cells [113], as well as, existence of feedback circuit at endocrine [114] and paracrine [115] loops. Here, GHR is linked to neoplasm.